Madrigal Pharmaceuticals (MDGL) PT Raised to $900 as Piper Sandler Recommends Buy
Tweet Send to a Friend
Piper Sandler analyst Yasmeen Rahimi raised the price target on Madrigal Pharmaceuticals (NASDAQ: MDGL) to $900.00 (from $540.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
